Logo image of QDEL

QUIDELORTHO CORP (QDEL) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:QDEL - US2197981051 - Common Stock

27.35 USD
-0.15 (-0.55%)
Last: 11/28/2025, 7:56:24 PM
27.35 USD
0 (0%)
After Hours: 11/28/2025, 7:56:24 PM
Fundamental Rating

3

Overall QDEL gets a fundamental rating of 3 out of 10. We evaluated QDEL against 188 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and financial health of QDEL have multiple concerns. QDEL has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year QDEL was profitable.
QDEL had a positive operating cash flow in the past year.
In multiple years QDEL reported negative net income over the last 5 years.
QDEL had a positive operating cash flow in each of the past 5 years.
QDEL Yearly Net Income VS EBIT VS OCF VS FCFQDEL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B -2B

1.2 Ratios

QDEL's Return On Assets of -20.78% is in line compared to the rest of the industry. QDEL outperforms 51.60% of its industry peers.
QDEL has a Return On Equity of -57.90%. This is comparable to the rest of the industry: QDEL outperforms 48.94% of its industry peers.
Looking at the Return On Invested Capital, with a value of 1.74%, QDEL is in the better half of the industry, outperforming 68.62% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for QDEL is below the industry average of 8.71%.
Industry RankSector Rank
ROA -20.78%
ROE -57.9%
ROIC 1.74%
ROA(3y)-8.62%
ROA(5y)9.28%
ROE(3y)-19.28%
ROE(5y)7.89%
ROIC(3y)4.37%
ROIC(5y)20.45%
QDEL Yearly ROA, ROE, ROICQDEL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60 -60

1.3 Margins

QDEL's Operating Margin of 3.98% is fine compared to the rest of the industry. QDEL outperforms 68.09% of its industry peers.
QDEL's Operating Margin has declined in the last couple of years.
QDEL has a Gross Margin of 47.15%. This is comparable to the rest of the industry: QDEL outperforms 40.96% of its industry peers.
QDEL's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 3.98%
PM (TTM) N/A
GM 47.15%
OM growth 3Y-68.75%
OM growth 5Y-39.02%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-14.83%
GM growth 5Y-5.07%
QDEL Yearly Profit, Operating, Gross MarginsQDEL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

1

2. Health

2.1 Basic Checks

QDEL has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
QDEL has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, QDEL has more shares outstanding
Compared to 1 year ago, QDEL has a worse debt to assets ratio.
QDEL Yearly Shares OutstandingQDEL Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
QDEL Yearly Total Debt VS Total AssetsQDEL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.2 Solvency

Based on the Altman-Z score of 0.76, we must say that QDEL is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of QDEL (0.76) is comparable to the rest of the industry.
QDEL has a Debt/Equity ratio of 1.23. This is a high value indicating a heavy dependency on external financing.
QDEL has a worse Debt to Equity ratio (1.23) than 77.13% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.23
Debt/FCF N/A
Altman-Z 0.76
ROIC/WACC0.24
WACC7.15%
QDEL Yearly LT Debt VS Equity VS FCFQDEL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B 4B 5B

2.3 Liquidity

A Current Ratio of 1.78 indicates that QDEL should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.78, QDEL is doing worse than 68.09% of the companies in the same industry.
QDEL has a Quick Ratio of 1.78. This is a bad value and indicates that QDEL is not financially healthy enough and could expect problems in meeting its short term obligations.
QDEL has a worse Quick ratio (0.98) than 76.60% of its industry peers.
Industry RankSector Rank
Current Ratio 1.78
Quick Ratio 0.98
QDEL Yearly Current Assets VS Current LiabilitesQDEL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

5

3. Growth

3.1 Past

QDEL shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -4.18%.
QDEL shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -9.03% yearly.
The Revenue has decreased by -3.67% in the past year.
The Revenue has been growing by 39.07% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-4.18%
EPS 3Y-52.97%
EPS 5Y-9.03%
EPS Q2Q%-5.88%
Revenue 1Y (TTM)-3.67%
Revenue growth 3Y17.89%
Revenue growth 5Y39.07%
Sales Q2Q%-3.74%

3.2 Future

QDEL is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 21.56% yearly.
Based on estimates for the next years, QDEL will show a small growth in Revenue. The Revenue will grow by 1.99% on average per year.
EPS Next Y14.78%
EPS Next 2Y18.22%
EPS Next 3Y21.95%
EPS Next 5Y21.56%
Revenue Next Year-2.4%
Revenue Next 2Y-0.09%
Revenue Next 3Y1.28%
Revenue Next 5Y1.99%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
QDEL Yearly Revenue VS EstimatesQDEL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1B 2B 3B
QDEL Yearly EPS VS EstimatesQDEL Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 5 10 15

6

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 11.94, which indicates a very decent valuation of QDEL.
Based on the Price/Earnings ratio, QDEL is valued cheaply inside the industry as 91.49% of the companies are valued more expensively.
When comparing the Price/Earnings ratio of QDEL to the average of the S&P500 Index (26.31), we can say QDEL is valued rather cheaply.
Based on the Price/Forward Earnings ratio of 10.58, the valuation of QDEL can be described as reasonable.
Based on the Price/Forward Earnings ratio, QDEL is valued cheaper than 93.62% of the companies in the same industry.
QDEL is valuated cheaply when we compare the Price/Forward Earnings ratio to 36.59, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 11.94
Fwd PE 10.58
QDEL Price Earnings VS Forward Price EarningsQDEL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, QDEL is valued cheaper than 94.15% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 8.08
QDEL Per share dataQDEL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as QDEL's earnings are expected to grow with 21.95% in the coming years.
PEG (NY)0.81
PEG (5Y)N/A
EPS Next 2Y18.22%
EPS Next 3Y21.95%

0

5. Dividend

5.1 Amount

No dividends for QDEL!.
Industry RankSector Rank
Dividend Yield N/A

QUIDELORTHO CORP

NASDAQ:QDEL (11/28/2025, 7:56:24 PM)

After market: 27.35 0 (0%)

27.35

-0.15 (-0.55%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-05 2025-11-05/amc
Earnings (Next)02-11 2026-02-11/amc
Inst Owners117.77%
Inst Owner Change3.71%
Ins Owners0.58%
Ins Owner Change1.22%
Market Cap1.86B
Revenue(TTM)2.71B
Net Income(TTM)-1.18B
Analysts74.29
Price Target37.59 (37.44%)
Short Float %13.51%
Short Ratio6.09
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)381.21%
Min EPS beat(2)70.71%
Max EPS beat(2)691.7%
EPS beat(4)4
Avg EPS beat(4)197.7%
Min EPS beat(4)4.59%
Max EPS beat(4)691.7%
EPS beat(8)7
Avg EPS beat(8)123.74%
EPS beat(12)10
Avg EPS beat(12)89.01%
EPS beat(16)13
Avg EPS beat(16)77.39%
Revenue beat(2)1
Avg Revenue beat(2)0.83%
Min Revenue beat(2)-1.53%
Max Revenue beat(2)3.19%
Revenue beat(4)1
Avg Revenue beat(4)-0.15%
Min Revenue beat(4)-1.53%
Max Revenue beat(4)3.19%
Revenue beat(8)4
Avg Revenue beat(8)0.51%
Revenue beat(12)8
Avg Revenue beat(12)2.03%
Revenue beat(16)11
Avg Revenue beat(16)2.72%
PT rev (1m)-10.83%
PT rev (3m)-16.23%
EPS NQ rev (1m)-41.5%
EPS NQ rev (3m)-46.16%
EPS NY rev (1m)-6.32%
EPS NY rev (3m)-12.6%
Revenue NQ rev (1m)-2.88%
Revenue NQ rev (3m)-3.79%
Revenue NY rev (1m)0.18%
Revenue NY rev (3m)-0.14%
Valuation
Industry RankSector Rank
PE 11.94
Fwd PE 10.58
P/S 0.68
P/FCF N/A
P/OCF 49.81
P/B 0.91
P/tB N/A
EV/EBITDA 8.08
EPS(TTM)2.29
EY8.37%
EPS(NY)2.59
Fwd EY9.45%
FCF(TTM)-2.25
FCFYN/A
OCF(TTM)0.55
OCFY2.01%
SpS39.96
BVpS29.98
TBVpS-8.41
PEG (NY)0.81
PEG (5Y)N/A
Graham Number39.3
Profitability
Industry RankSector Rank
ROA -20.78%
ROE -57.9%
ROCE 2.2%
ROIC 1.74%
ROICexc 1.78%
ROICexgc 3.88%
OM 3.98%
PM (TTM) N/A
GM 47.15%
FCFM N/A
ROA(3y)-8.62%
ROA(5y)9.28%
ROE(3y)-19.28%
ROE(5y)7.89%
ROIC(3y)4.37%
ROIC(5y)20.45%
ROICexc(3y)4.54%
ROICexc(5y)30.14%
ROICexgc(3y)17.29%
ROICexgc(5y)56.29%
ROCE(3y)5.53%
ROCE(5y)25.88%
ROICexgc growth 3Y-72.1%
ROICexgc growth 5Y-43.85%
ROICexc growth 3Y-77.1%
ROICexc growth 5Y-42.97%
OM growth 3Y-68.75%
OM growth 5Y-39.02%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-14.83%
GM growth 5Y-5.07%
F-Score5
Asset Turnover0.48
Health
Industry RankSector Rank
Debt/Equity 1.23
Debt/FCF N/A
Debt/EBITDA 4.57
Cap/Depr 43.31%
Cap/Sales 7%
Interest Coverage 250
Cash Conversion 6.82%
Profit Quality N/A
Current Ratio 1.78
Quick Ratio 0.98
Altman-Z 0.76
F-Score5
WACC7.15%
ROIC/WACC0.24
Cap/Depr(3y)46.16%
Cap/Depr(5y)161.74%
Cap/Sales(3y)6.1%
Cap/Sales(5y)7.89%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-4.18%
EPS 3Y-52.97%
EPS 5Y-9.03%
EPS Q2Q%-5.88%
EPS Next Y14.78%
EPS Next 2Y18.22%
EPS Next 3Y21.95%
EPS Next 5Y21.56%
Revenue 1Y (TTM)-3.67%
Revenue growth 3Y17.89%
Revenue growth 5Y39.07%
Sales Q2Q%-3.74%
Revenue Next Year-2.4%
Revenue Next 2Y-0.09%
Revenue Next 3Y1.28%
Revenue Next 5Y1.99%
EBIT growth 1Y4.34%
EBIT growth 3Y-63.16%
EBIT growth 5Y-15.19%
EBIT Next Year80.92%
EBIT Next 3Y30.1%
EBIT Next 5Y22.82%
FCF growth 1Y-203.95%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-89.9%
OCF growth 3Y-53.13%
OCF growth 5Y-9.2%

QUIDELORTHO CORP / QDEL FAQ

Can you provide the ChartMill fundamental rating for QUIDELORTHO CORP?

ChartMill assigns a fundamental rating of 3 / 10 to QDEL.


What is the valuation status of QUIDELORTHO CORP (QDEL) stock?

ChartMill assigns a valuation rating of 6 / 10 to QUIDELORTHO CORP (QDEL). This can be considered as Fairly Valued.


What is the profitability of QDEL stock?

QUIDELORTHO CORP (QDEL) has a profitability rating of 3 / 10.


Can you provide the expected EPS growth for QDEL stock?

The Earnings per Share (EPS) of QUIDELORTHO CORP (QDEL) is expected to grow by 14.78% in the next year.